Statistik Asas
Pengurus | Mark N. Lampert |
Profil Orang Dalam | BIOTECHNOLOGY VALUE FUND L P |
Nilai Portfolio | $ 3,221,842,995 |
Kedudukan Semasa | 55 |
Kedudukan Aktivis | 37 |
Pemfailan 13D/G
Ini ialah senarai pemfailan 13D dan 13G yang dibuat pada tahun lepas (jika ada). Klik ikon pautan untuk melihat sejarah transaksi penuh. Baris hijau menunjukkan kedudukan baharu. Baris merah menunjukkan kedudukan tertutup.
Tarikh Fail | Borang | Sekuriti | Saham Terdahulu |
Saham Semasa |
ΔSaham % | % Pemilikan |
% ΔPemilikan | |
---|---|---|---|---|---|---|---|---|
2025-08-20 | XFOR / X4 Pharmaceuticals, Inc. | 2,258,400 | 2,243,659 | -0.65 | 9.90 | 421.05 | ||
2025-08-18 | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 2,438,964 | 9,611,751 | 294.09 | 5.60 | 211.11 | ||
2025-08-14 | VIGL / Vigil Neuroscience, Inc. | 4,734,500 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-08-14 | UNCY / Unicycive Therapeutics, Inc. | 1,417,117 | 9.99 | |||||
2025-08-14 | VERV / Verve Therapeutics, Inc. | 6,904,050 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-08-14 | CBIO / Crescent Biopharma, Inc. | 0 | 1,387,863 | 9.99 | ||||
2025-08-14 | ITOS / iTeos Therapeutics, Inc. | 3,075,000 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-08-14 | IMUX / Immunic, Inc. | 8,902,972 | 9,785,178 | 9.91 | 9.99 | 0.91 | ||
2025-08-13 | VSTM / Verastem, Inc. | 4,706,551 | 5,720,831 | 21.55 | 9.99 | 0.00 | ||
2025-08-07 | EPIX / ESSA Pharma Inc. | 8,748,629 | 11,668,473 | 33.37 | 24.70 | 25.38 | ||
2025-07-21 | OVID / Ovid Therapeutics Inc. | 3,853,818 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-07-09 | NKTR / Nektar Therapeutics | 1,276,595 | 7.40 | |||||
2025-07-09 | CTMX / CytomX Therapeutics, Inc. | 8,089,795 | 11,538,462 | 42.63 | 6.80 | -31.93 | ||
2025-06-16 | PTGX / Protagonist Therapeutics, Inc. | 2,970,427 | 3,211,041 | 8.10 | 5.20 | 6.12 | ||
2025-05-20 | XOMA / XOMA Royalty Corporation | 2,983,026 | 2,590,303 | -13.17 | 21.60 | -14.62 | ||
2025-05-19 | ALLK / Allakos Inc. | 16,552,417 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-05-15 | CDTX / Cidara Therapeutics, Inc. | 1,093,499 | 1,252,441 | 14.54 | 9.99 | 0.00 | ||
2025-05-15 | GHRS / GH Research PLC | 10,400,158 | 8,827,712 | -15.12 | 14.20 | -28.96 | ||
2025-05-15 | FDMT / 4D Molecular Therapeutics, Inc. | 4,834,297 | 4,632,749 | -4.17 | 9.99 | 0.00 | ||
2025-05-15 | ELEV / Elevation Oncology, Inc. | 6,230,845 | 4,440,000 | -28.74 | 7.00 | -29.93 | ||
2025-05-15 | GLUE / Monte Rosa Therapeutics, Inc. | 4,393,210 | 5,660,132 | 28.84 | 9.20 | 27.78 | ||
2025-05-15 | SEPN / Septerna, Inc. | 2,452,024 | 4,396,124 | 79.29 | 9.90 | 80.00 | ||
2025-05-15 | TCRX / TScan Therapeutics, Inc. | 5,073,003 | 5,263,541 | 3.76 | 9.99 | 0.00 | ||
2025-05-09 | IVA / Inventiva S.A. - Depositary Receipt (Common Stock) | 8,545,499 | 8,545,499 | 0.00 | 6.10 | -32.22 | ||
2025-04-16 | THRD / Third Harmonic Bio, Inc. | 2,372,933 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-02-14 | FBRX / Forte Biosciences, Inc. | 2,982,105 | 643,622 | -78.42 | 9.99 | 21.83 | ||
2025-02-14 | ETNB / 89bio, Inc. | 6,811,631 | 4,333,885 | -36.38 | 3.60 | -43.75 | ||
2025-02-14 | AVTX / Avalo Therapeutics, Inc. | 967,299 | 1,038,542 | 7.37 | 9.99 | 0.00 | ||
2025-02-14 | TYRA / Tyra Biosciences, Inc. | 4,661,194 | 3,944,194 | -15.38 | 7.80 | -11.36 | ||
2025-02-14 | VTGN / Vistagen Therapeutics, Inc. | 2,777,245 | 3,084,324 | 11.06 | 9.97 | -0.20 | ||
2025-02-14 | IKNA / Ikena Oncology, Inc. | 4,769,164 | 4,006,564 | -15.99 | 8.30 | -16.16 | ||
2025-02-04 | KURA / Kura Oncology, Inc. | 4,212,346 | 5,912,554 | 40.36 | 7.50 | 38.89 | ||
2025-01-29 | ENGN / enGene Holdings Inc. | 3,196,439 | 945,402 | -70.42 | 1.80 | -75.00 | ||
2025-01-06 | RAPT / RAPT Therapeutics, Inc. | 11,764,000 | 8.70 | |||||
2024-12-17 | PVLA / Palvella Therapeutics, Inc. | 1,168,117 | 9.99 | |||||
2024-12-04 | OLMA / Olema Pharmaceuticals, Inc. | 9,135,893 | 7,557,237 | -17.28 | 9.99 | -40.18 | ||
2024-11-14 | MTEM / Molecular Templates, Inc. | 537,426 | 672,767 | 25.18 | 9.99 | 0.00 | ||
2024-11-14 | ACIU / AC Immune SA | 14,571,236 | 19,522,436 | 33.98 | 19.70 | 33.11 | ||
2024-11-14 | VIRX / Viracta Therapeutics, Inc. | 3,833,785 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | LXRX / Lexicon Pharmaceuticals, Inc. | 24,435,632 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | STRO / Sutro Biopharma, Inc. | 3,347,946 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | RGLS / Regulus Therapeutics Inc. | 9,661,235 | 883,844 | -90.85 | 1.30 | -86.99 | ||
2024-11-14 | ANTX / AN2 Therapeutics, Inc. | 1,563,963 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | ZYME / Zymeworks Inc. | 5,870,000 | 4,607,935 | -21.50 | 6.50 | -30.11 | ||
2024-11-14 | CGEM / Cullinan Therapeutics, Inc. | 4,393,321 | 5,796,433 | 31.94 | 9.99 | 0.00 | ||
2024-11-14 | JANX / Janux Therapeutics, Inc. | 4,579,818 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | IDYA / IDEAYA Biosciences, Inc. | 3,479,043 | 1,409,993 | -59.47 | 1.70 | -67.92 | ||
2024-11-14 | DCTH / Delcath Systems, Inc. | 2,338,426 | 1,041,667 | -55.45 | 3.60 | -63.96 | ||
2024-11-14 | CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) | 8,774,570 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | ANNX / Annexon, Inc. | 7,000,000 | 9,027,778 | 28.97 | 8.40 | -5.62 | ||
2024-11-14 | MIRM / Mirum Pharmaceuticals, Inc. | 4,370,024 | 3,075,907 | -29.61 | 6.40 | -31.91 | ||
2024-10-31 | ELDN / Eledon Pharmaceuticals, Inc. | 4,326,710 | 6,293,282 | 45.45 | 10.50 | -41.34 | ||
2024-10-29 | MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) | 8,696,205 | 9,888,592 | 13.71 | 24.50 | 2.51 | ||
2024-10-08 | MLTX / MoonLake Immunotherapeutics | 21,751,284 | 19,751,284 | -9.19 | 31.40 | -9.25 | ||
2024-09-11 | CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock) | 6,260,311 | 0 | -100.00 | 0.00 | -100.00 |